Liu Jing, Akter Reshmi, Rupa Esrat Jahan, Van-An Hoang, Li Jinfeng, Yang Deok Chun, Yang Dong Uk, Awais Muhammad, Kim Jong-Hoon
Jilin Ginseng Academy, Changchun University of Chinese Medicine, Changchun, China.
Graduate School of Biotechnology, College of Life Sciences, Kyung Hee University, Yongin-si, Gyeonggido, Republic of Korea.
Front Pharmacol. 2025 May 21;16:1564131. doi: 10.3389/fphar.2025.1564131. eCollection 2025.
Phytoestrogen-rich plants have been used across various traditional medicine systems, such as Ayurveda, Traditional Chinese Medicine, and Indigenous herbal practices, to address menopausal symptoms including metabolic imbalances and weight gain. The historical use of these plants underscores their therapeutic potential in women's health, providing a foundation for exploring their modern applications as safer alternatives to hormone replacement therapy (HRT) for post-menopausal obesity.
This review aims to systematically evaluate the anti-obesity effects of plant-derived phytoestrogens in managing post-menopausal obesity. It seeks to understand and summarize the mechanisms by which phytoestrogens act as estrogen alternatives, focusing on their cellular and molecular effects, and highlighting specific plants with promising therapeutic properties.
A comprehensive literature search was conducted, covering studies on phytoestrogenic plants used in traditional and contemporary practices for managing obesity. The review examines each plant's taxonomic family, common name, bioactive compounds, and experimental evidence from cellular and animal models that illustrate potential anti-obesity mechanisms relevant to post-menopausal conditions.
The analysis reveals that phytoestrogens employ diverse mechanisms in mitigating obesity. Some bind directly to estrogen receptors, mimicking estrogenic effects and inducing cellular responses linked to metabolism. Others inhibit adipogenesis (fat cell formation) and lipogenesis (fat storage), while some enhance thermogenesis (heat production) and lipolysis (fat breakdown), effectively counteracting the metabolic shifts associated with menopause. Specific plants, such as soy ( (L.) Merr.), red clover ( L.), and basil-clove ( L.), demonstrate unique pathways for influencing fat metabolism, suggesting a multi-faceted approach to post-menopausal obesity.
Plant-derived phytoestrogens have been proposed as a potential alternative to HRT for managing post-menopausal obesity. Drawing from both traditional ethnobotanical knowledge and emerging scientific evidence, these compounds may offer a naturally derived strategy that could carry fewer adverse effects. Nevertheless, current findings are preliminary, and more rigorous, large-scale clinical studies are necessary to better understand their efficacy, determine appropriate dosing, and assess possible interactions with conventional therapies.
富含植物雌激素的植物已被用于各种传统医学体系,如阿育吠陀医学、传统中医和本土草药疗法,以解决包括代谢失衡和体重增加在内的更年期症状。这些植物的历史应用突出了它们在女性健康方面的治疗潜力,为探索它们作为绝经后肥胖激素替代疗法(HRT)更安全替代品的现代应用奠定了基础。
本综述旨在系统评估植物源性植物雌激素在管理绝经后肥胖方面的抗肥胖作用。它试图理解和总结植物雌激素作为雌激素替代品发挥作用的机制,重点关注其细胞和分子效应,并突出具有潜在治疗特性的特定植物。
进行了全面的文献检索,涵盖了传统和现代实践中用于管理肥胖的植物雌激素植物的研究。该综述研究了每种植物的分类科、通用名称、生物活性化合物,以及来自细胞和动物模型的实验证据,这些证据说明了与绝经后状况相关的潜在抗肥胖机制。
分析表明,植物雌激素在减轻肥胖方面采用多种机制。一些直接与雌激素受体结合,模拟雌激素效应并诱导与代谢相关的细胞反应。其他的则抑制脂肪生成(脂肪细胞形成)和脂肪生成(脂肪储存),而一些则增强产热(热量产生)和脂肪分解(脂肪分解),有效对抗与更年期相关的代谢变化。特定植物,如大豆((L.)Merr.)、红三叶草(L.)和罗勒丁香(L.),展示了影响脂肪代谢的独特途径,表明对绝经后肥胖采取多方面的方法。
植物源性植物雌激素已被提议作为管理绝经后肥胖的HRT潜在替代品。借鉴传统民族植物学知识和新出现的科学证据来看,这些化合物可能提供一种天然衍生的策略,可能具有较少的不良反应。然而,目前的研究结果是初步的,需要更严格的大规模临床研究来更好地了解它们的疗效、确定合适的剂量,并评估与传统疗法可能的相互作用。